Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and Beta Cell Function in Newly-diagnosed Type 2 Diabetic Patients
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Feb 2013 New trial record
- 13 Feb 2013 Biomarkers information updated